Controversy Surrounds Regulatory Approval of Abortion Pill in the US
TL;DR Summary
A US judge is considering a request by anti-abortion groups to ban sales of the abortion pill mifepristone nationwide, questioning whether the federal regulatory approval given to the drug 22 years ago was proper. The case follows the US Supreme Court's abortion rights reversal, and the plaintiffs are asking for a preliminary order halting sales of mifepristone nationwide while their lawsuit proceeds. If the judge rules against the FDA, it would hinder abortion access in every state as medication abortion, with mifepristone part of a two-pill regimen, accounts for more than half of US abortions.
- Judge mulls banning abortion pill in US, questions regulatory approval Reuters
- Texas judge seems open to argument abortion drug not properly vetted The Washington Post
- Matthew Kacsmaryk: The Trump-appointed judge overseeing the blockbuster medication abortion lawsuit CNN
- Conservatives look to block access to medical abortion pill Sacramento Bee
- Editorial: Judge's attempt to keep abortion hearing secret speaks volumes about his bias St. Louis Post-Dispatch
Reading Insights
Total Reads
0
Unique Readers
12
Time Saved
4 min
vs 5 min read
Condensed
90%
964 → 95 words
Want the full story? Read the original article
Read on Reuters